Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders

E-ISSN： 2212-3334|1|2|157-161

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.1, Iss.2, 2007-06, pp. : 157-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 3, 2012-09 ,pp. : 235-250

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Melatonin in Neurological Disorders

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 1, 2009-01 ,pp. : 60-64

Bentham Science Publishers

Access to resources Recommend Favorite

Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 84-95

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives in Therapeutic Innovation in Ocular Surface Disorders and Dry Eye Syndrome

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 194-199

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of the Chronobiological and Non-chronobiological Actions of Melatonin for Enhancing Therapeutic Efficacy in Neurodegenerative Disorders

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 2, 2011-05 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite